{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:09:00Z","timestamp":1779430140535,"version":"3.53.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00417-026-07145-z","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:25:24Z","timestamp":1772173524000},"page":"1541-1558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and safety of intravenous thrombolysis for non-arteritic central retinal artery occlusion: A GRADE-assessed meta\u2010analysis"],"prefix":"10.1007","volume":"264","author":[{"given":"Abdallah","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneen","family":"Sabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina Essam","family":"Abo-elnour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"Al-Mufti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed","family":"Aldehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Alnaami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh N.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"1","key":"7145_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11940-012-0202-9","volume":"15","author":"S Cugati","year":"2013","unstructured":"Cugati S, Varma DD, Chen CS, Lee AW (2013) Treatment options for central retinal artery occlusion. Curr Treat Options Neurol 15(1):63\u201377","journal-title":"Curr Treat Options Neurol"},{"issue":"6","key":"7145_CR2","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/112067211002000603","volume":"20","author":"AK Rudkin","year":"2010","unstructured":"Rudkin AK, Lee AW, Chen CS (2010) Ocular neovascularization following central retinal artery occlusion: prevalence and timing of onset. Eur J Ophthalmol 20(6):1042\u20131046","journal-title":"Eur J Ophthalmol"},{"issue":"10","key":"7145_CR3","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1001\/archopht.1982.01030040563002","volume":"100","author":"SS Hayreh","year":"1982","unstructured":"Hayreh SS, Podhajsky P (1982) Ocular neovascularization with retinal vascular occlusion: II. occurrence in central and branch retinal artery occlusion. Arch Ophthalmol 100(10):1585\u201396","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"7145_CR4","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000366","volume":"52","author":"B Mac Grory","year":"2021","unstructured":"Mac Grory B, Schrag M, Biousse V, Furie KL, Gerhard-Herman M, Lavin PJ et al (2021) Management of central retinal artery occlusion: a scientific statement from the American Heart Association. Stroke 52(6):e282\u2013e294","journal-title":"Stroke"},{"issue":"12","key":"7145_CR5","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.4103\/ijo.IJO_1446_18","volume":"66","author":"SS Hayreh","year":"2018","unstructured":"Hayreh SS (2018) Central retinal artery occlusion. Indian J Ophthalmol 66(12):1684\u20131694","journal-title":"Indian J Ophthalmol"},{"key":"7145_CR6","doi-asserted-by":"crossref","unstructured":"Avery MB, Magal I, Kherani A, Mitha AP (2019) Risk of stroke in patients with ocular arterial occlusive disorders: a retrospective Canadian study. J Am Heart Assoc [Internet] [cited 2025 June 18]8(3). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30712440\/","DOI":"10.1161\/JAHA.118.010509"},{"issue":"26","key":"7145_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004075","volume":"95","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Zhu W, Wang C (2016) Relationship between retinal vascular occlusions and incident cerebrovascular diseases: a systematic review and meta-analysis. Medicine (Baltimore) 95(26):e4075","journal-title":"Medicine (Baltimore)"},{"key":"7145_CR8","unstructured":"Tripathy K, Shah SS, Waymack JR (2024) Central retinal artery occlusion. In: StatPearls [Internet] [Internet]. StatPearls Publishing [cited 2025 June 18]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470354\/"},{"issue":"2","key":"7145_CR9","doi-asserted-by":"publisher","first-page":"P120","DOI":"10.1016\/j.ophtha.2016.09.024","volume":"124","author":"TW Olsen","year":"2017","unstructured":"Olsen TW, Pulido JS, Folk JC, Hyman L, Flaxel CJ, Adelman RA (2017) Retinal and ophthalmic artery occlusions preferred practice pattern\u00ae. Ophthalmology 124(2):P120\u2013P143","journal-title":"Ophthalmology"},{"issue":"1","key":"7145_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4103\/tjo.tjo_61_20","volume":"11","author":"RA Sharma","year":"2020","unstructured":"Sharma RA, Newman NJ, Biousse V (2020) Conservative treatments for acute nonarteritic central retinal artery occlusion: do they work? Taiwan J Ophthalmol 11(1):16\u201324","journal-title":"Taiwan J Ophthalmol"},{"issue":"7","key":"7145_CR11","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.ophtha.2010.03.061","volume":"117","author":"M Schumacher","year":"2010","unstructured":"Schumacher M, Schmidt D, Jurklies B, Gall C, Wanke I, Schmoor C et al (2010) Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 117(7):1367-1375.e1","journal-title":"Ophthalmology"},{"issue":"3","key":"7145_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/WNO.0000000000001027","volume":"40","author":"OM Dumitrascu","year":"2020","unstructured":"Dumitrascu OM, Newman NJ, Biousse V (2020) Thrombolysis for central retinal artery occlusion in 2020: time is vision! J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc 40(3):333\u2013345","journal-title":"J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc"},{"issue":"7","key":"7145_CR13","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1161\/STROKEAHA.119.028743","volume":"51","author":"B Mac Grory","year":"2020","unstructured":"Mac Grory B, Nackenoff A, Poli S, Spitzer MS, Nedelmann M, Guillon B et al (2020) Intravenous fibrinolysis for central retinal artery occlusion: a cohort study and updated patient-level meta-analysis. Stroke 51(7):2018\u20132025","journal-title":"Stroke"},{"key":"7145_CR14","unstructured":"Safety and effectiveness of IV Thrombolysis in retinal artery occlusion: a multicenter retrospective cohort study - PubMed [Internet]. [cited 2025 July 11]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37421135\/"},{"key":"7145_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2024.102204","volume":"36","author":"AL Gilbert","year":"2024","unstructured":"Gilbert AL, Patel AP, Sax D, Bhatti MT, Shah R, Dokey A et al (2024) A telemedicine-enabled intravenous thrombolytic treatment pathway for patients with hyperacute non-arteritic central retinal artery occlusion. Am J Ophthalmol Case Rep 36:102204","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"1","key":"7145_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47987-9","volume":"13","author":"P Kozner","year":"2023","unstructured":"Kozner P, Eichenmann L, CeskaBurdova M, Pavlikova M, Hlozanek M, Dotrelova D (2023) Long-term outcomes of intravenous fibrinolysis in central retinal artery occlusion. Sci Rep 13(1):20505","journal-title":"Sci Rep"},{"issue":"2","key":"7145_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00415-022-11439-7","volume":"270","author":"FP Raber","year":"2023","unstructured":"Raber FP, Gmeiner FV, Dreyhaupt J, Wolf A, Ludolph AC, Werner JU et al (2023) Thrombolysis in central retinal artery occlusion: a retrospective observational study. J Neurol 270(2):891\u2013897","journal-title":"J Neurol"},{"issue":"4","key":"7145_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107610","volume":"33","author":"C Stretz","year":"2024","unstructured":"Stretz C, Paddock JE, Burton TM, Bakaeva T, Freeman M, Choudhury A et al (2024) IV thrombolysis for central retinal artery occlusion - real-world experience from a comprehensive stroke center. J Stroke Cerebrovasc Dis 33(4):107610","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"7145_CR19","unstructured":"Cochrane handbook for systematic reviews of interventions [Internet]. [cited 2024 July 17]. Available from: https:\/\/training.cochrane.org\/handbook"},{"key":"7145_CR20","unstructured":"PRISMA statement [Internet]. [cited 2024 July 17]. PRISMA 2020 checklist. Available from: https:\/\/www.prisma-statement.org\/prisma-2020-checklist"},{"issue":"1","key":"7145_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5(1):210","journal-title":"Syst Rev"},{"issue":"366","key":"7145_CR22","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 28(366):l4898","journal-title":"BMJ"},{"key":"7145_CR23","unstructured":"Ottawa Hospital Research Institute [Internet]. [cited 2024 Dec 14]. Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"7145_CR24","unstructured":"RevMan Knowledge Base - RMW Knowledge Base [Internet]. [cited 2024 Dec 18]. Available from: https:\/\/documentation.cochrane.org\/revman-kb\/revman-knowledge-base-55377928.html"},{"key":"7145_CR25","doi-asserted-by":"publisher","unstructured":"Guillon B, Preterre C, Obadia M, Mourand I, Gaudron M, Sablot D et al (2024) A randomized controlled trial of alteplase initiated within 4.5 hours of central retinal artery occlusion. The Theia study. In: 16th World Stroke Congress, 23\u201326 October 2024, Abu Dhabi, UAE [Internet]. International Journal of Stroke [cited 2025 July 10]. p 3\u2013498. Available from: https:\/\/doi.org\/10.1177\/17474930241274956","DOI":"10.1177\/17474930241274956"},{"issue":"4","key":"7145_CR26","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1177\/23969873231185895","volume":"8","author":"P Baumgartner","year":"2023","unstructured":"Baumgartner P, Kook L, Altersberger VL, Gensicke H, Ardila-Jurado E, K\u00e4gi G et al (2023) Safety and effectiveness of IV thrombolysis in retinal artery occlusion: a multicenter retrospective cohort study. Eur Stroke J 8(4):966\u2013973","journal-title":"Eur Stroke J"},{"issue":"3","key":"7145_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u201388","journal-title":"Control Clin Trials"},{"key":"7145_CR28","unstructured":"9.5.2 Identifying and measuring heterogeneity [Internet]. [cited 2024 Nov 6]. Available from: https:\/\/handbook-5-1.cochrane.org\/chapter_9\/9_5_2_identifying_and_measuring_heterogeneity.htm"},{"key":"7145_CR29","unstructured":"9.5.3 Strategies for addressing heterogeneity [Internet]. [cited 2024 Aug 13]. Available from: https:\/\/handbook-5-1.cochrane.org\/chapter_9\/9_5_3_strategies_for_addressing_heterogeneity.htm"},{"issue":"4","key":"7145_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","volume":"16","author":"L Furuya-Kanamori","year":"2018","unstructured":"Furuya-Kanamori L, Barendregt JJ, Doi SAR (2018) A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc 16(4):195\u2013203","journal-title":"Int J Evid Based Healthc"},{"issue":"2","key":"7145_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/01658107.2023.2290536","volume":"48","author":"N Alhayek","year":"2024","unstructured":"Alhayek N, Sobczak JM, Vanood A, O\u2019Carroll CB, Demaerschalk BM, Chen J et al (2024) Thrombolytic therapy for central retinal artery occlusion in an academic multi-site stroke centre. Neuro-Ophthalmology 48(2):111\u2013121. https:\/\/doi.org\/10.1080\/01658107.2023.2290536","journal-title":"Neuro-Ophthalmology"},{"issue":"5","key":"7145_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198114","volume":"13","author":"M Schultheiss","year":"2018","unstructured":"Schultheiss M, H\u00e4rtig F, Spitzer MS, Feltgen N, Spitzer B, H\u00fcsing J et al (2018) Intravenous thrombolysis in acute central retinal artery occlusion \u2013 a prospective interventional case series. PLoS One 13(5):e0198114","journal-title":"PLoS One"},{"issue":"4","key":"7145_CR33","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.3892\/etm.2016.3681","volume":"12","author":"XJ Wu","year":"2016","unstructured":"Wu XJ, Gao F, Liu X, Zhao Q (2016) Observation on therapeutic efficacy of rt-PA intravenous thrombolysis combined with compound anisodine injection on central retinal artery occlusion. Exp Ther Med 12(4):2617\u20132621","journal-title":"Exp Ther Med"},{"issue":"8","key":"7145_CR34","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1161\/STROKEAHA.111.613653","volume":"42","author":"CS Chen","year":"2011","unstructured":"Chen CS, Lee AW, Campbell B, Lee T, Paine M, Fraser C et al (2011) Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial. Stroke 42(8):2229\u20132234","journal-title":"Stroke"},{"issue":"3","key":"7145_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ajo.2005.03.038","volume":"140","author":"SS Hayreh","year":"2005","unstructured":"Hayreh SS, Zimmerman MB (2005) Central retinal artery occlusion: visual outcome. Am J Ophthalmol 140(3):376\u2013391","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"7145_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-022-00193-w","volume":"4","author":"C Hoyer","year":"2022","unstructured":"Hoyer C, Winzer S, Matth\u00e9 E, Heinle I, Sandikci V, Nabavi D et al (2022) Current diagnosis and treatment practice of central retinal artery occlusion: results from a survey among German stroke units. Neurol Res Pract 4(1):30","journal-title":"Neurol Res Pract"},{"issue":"10","key":"7145_CR37","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.ophtha.2007.06.047","volume":"114","author":"RW Beck","year":"2007","unstructured":"Beck RW, Maguire MG, Bressler NM, Glassman AR, Lindblad AS, Ferris FL (2007) Visual acuity as an outcome measure in clinical trials of retinal diseases. Ophthalmology 114(10):1804\u20131809","journal-title":"Ophthalmology"},{"key":"7145_CR38","doi-asserted-by":"crossref","unstructured":"Bennett CR, Bex PJ, Bauer CM, Merabet LB (2019) The assessment of visual function and functional vision. Semin Pediatr Neurol [Internet] [cited 2025 June 27]31:30\u201340. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6761988\/","DOI":"10.1016\/j.spen.2019.05.006"},{"issue":"10","key":"7145_CR39","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","volume":"72","author":"M Schrag","year":"2015","unstructured":"Schrag M, Youn T, Schindler J, Kirshner H, Greer D (2015) Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis. JAMA Neurol 72(10):1148\u20131154","journal-title":"JAMA Neurol"},{"issue":"2","key":"7145_CR40","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/STROKEAHA.119.027478","volume":"51","author":"B Mac Grory","year":"2020","unstructured":"Mac Grory B, Lavin P, Kirshner H, Schrag M (2020) Thrombolytic therapy for acute central retinal artery occlusion. Stroke 51(2):687\u2013695. https:\/\/doi.org\/10.1161\/STROKEAHA.119.027478","journal-title":"Stroke"},{"key":"7145_CR41","doi-asserted-by":"crossref","unstructured":"Hayreh SS, Zimmerman MB, Kimura A, Sanon A (2004) Central retinal artery occlusion: retinal survival time. Exp Eye Res [Internet] [cited 2025 June 28] 78(3):723\u201336. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0014483503002148","DOI":"10.1016\/S0014-4835(03)00214-8"},{"issue":"3","key":"7145_CR42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0014-4835(03)00214-8","volume":"78","author":"SS Hayreh","year":"2004","unstructured":"Hayreh SS, Zimmerman MB, Kimura A, Sanon A (2004) Central retinal artery occlusion. Retinal survival time. Exp Eye Res 78(3):723\u2013736","journal-title":"Exp Eye Res"},{"issue":"2","key":"7145_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/08820538.2023.2249539","volume":"39","author":"Y Liu","year":"2024","unstructured":"Liu Y, Cao S, Zhao Y, Wu T, Wang Q (2024) Network meta-analysis of different thrombolytic strategies for the treatment of central retinal artery occlusion. Semin Ophthalmol 39(2):129\u2013138","journal-title":"Semin Ophthalmol"},{"issue":"2","key":"7145_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s13167-018-0136-8","volume":"9","author":"BA Sabel","year":"2018","unstructured":"Sabel BA, Wang J, C\u00e1rdenas-Morales L, Faiq M, Heim C (2018) Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthalmology for preventive and personalized medicine. EPMA J 9(2):133\u2013160","journal-title":"EPMA J"},{"issue":"3","key":"7145_CR45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/IAE.0b013e3182a0e42e","volume":"34","author":"M Weger","year":"2014","unstructured":"Weger M, Pichler T, Franke GH, Haas A, Thaler HV, Kraigher-Krainer N et al (2014) Assessment of vision-related quality of life in patients with central retinal artery occlusion. Retina 34(3):539\u2013545","journal-title":"Retina"},{"issue":"4","key":"7145_CR46","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nrn3200","volume":"13","author":"JH Morrison","year":"2012","unstructured":"Morrison JH, Baxter MG (2012) The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat Rev Neurosci 13(4):240\u2013250","journal-title":"Nat Rev Neurosci"},{"key":"7145_CR47","doi-asserted-by":"publisher","first-page":"888456","DOI":"10.3389\/fneur.2022.888456\/full","volume":"13","author":"E ArdilaJurado","year":"2022","unstructured":"ArdilaJurado E, Sturm V, Brugger F, Nedeltchev K, Arnold M, Bonati LH et al (2022) Central retinal artery occlusion: current practice, awareness and prehospital delays in Switzerland. Front Neurol 13:888456. https:\/\/doi.org\/10.3389\/fneur.2022.888456\/full","journal-title":"Front Neurol"},{"key":"7145_CR48","doi-asserted-by":"crossref","unstructured":"Kang EYC, Lin YH, Wang NK, Yeung L, Luo C, Wu WC et al (2019) Aspirin use in central retinal arterial occlusion to prevent ischaemic stroke: a retrospective cohort study in Taiwan. BMJ Open [Internet] [cited 2025 July 14] 9(2):e025455. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6398622\/","DOI":"10.1136\/bmjopen-2018-025455"},{"key":"7145_CR49","unstructured":"The preliminary results of TenCRAOS (2025) [Internet] Twitter [cited 2025 Aug 11]. Available from: https:\/\/x.com\/WorldStrokeEd\/status\/1925840282014081354"},{"key":"7145_CR50","first-page":"239698732513441","volume":"12","author":"SJ Ryan","year":"2025","unstructured":"Ryan SJ, J\u00f8rstad \u00d8K, Skjelland M, Simonsen CZ, Bek T, Blauenfeldt RA et al (2025) Tenecteplase in central retinal artery occlusion study (TenCRAOS): protocol for a randomized-controlled trial. Eur Stroke J 12:23969873251344200","journal-title":"Eur Stroke J"},{"issue":"1","key":"7145_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00417-022-05797-1","volume":"261","author":"L Huang","year":"2023","unstructured":"Huang L, Wang Y, Zhang R (2023) Efficacy and safety of intra-arterial thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol 261(1):103\u2013113","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7145_CR52","doi-asserted-by":"publisher","unstructured":"When does it make sense to perform a meta\u2010analysis? - Introduction to Meta\u2010Analysis - Wiley Online Library [Internet]. [cited 2025 Aug 18]. Available from: https:\/\/doi.org\/10.1002\/9780470743386.ch40","DOI":"10.1002\/9780470743386.ch40"},{"issue":"4","key":"7145_CR53","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00415-021-10838-6","volume":"269","author":"L Huang","year":"2022","unstructured":"Huang L, Wang Y, Zhang R (2022) Intravenous thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis. J Neurol 269(4):1825\u20131833. https:\/\/doi.org\/10.1007\/s00415-021-10838-6","journal-title":"J Neurol"},{"issue":"13","key":"7145_CR54","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E, Brozman M, D\u00e1valos A, Guidetti D et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317\u20131329. https:\/\/doi.org\/10.1056\/NEJMoa0804656","journal-title":"N Engl J Med"},{"key":"7145_CR55","doi-asserted-by":"crossref","unstructured":"Wahlgren N, Ahmed N, D\u00e1valos A, Ford GA, Grond M, Hacke W et al (2007) Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet [Internet] [cited 2025 June 29] 369(9558):275\u201382. Available from: https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(07)60149-4\/abstract","DOI":"10.1016\/S0140-6736(07)60149-4"},{"issue":"11","key":"7145_CR56","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1161\/STROKEAHA.124.049955","volume":"56","author":"JS Xie","year":"2025","unstructured":"Xie JS, Zaslavsky K, Chaban YV, Lusterio A, Kaur H, Motekalem Y et al (2025) Early thrombolysis and outcomes in central retinal artery occlusion: an individual participant data meta-analysis. Stroke 56(11):3175\u20133186","journal-title":"Stroke"},{"issue":"6","key":"7145_CR57","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.ajo.2009.02.024","volume":"147","author":"KG Falavarjani","year":"2009","unstructured":"Falavarjani KG, Modarres M (2009) Intravenous tissue plasminogen activator in central retinal artery occlusion. Am J Ophthalmol 147(6):1105","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07145-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07145-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07145-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:48:54Z","timestamp":1779428934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07145-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7145"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07145-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We confirm that this manuscript complies with all instructions to authors, that all authors meet the authorship criteria and have approved the final version of the manuscript, and the PRISMA checklist was used.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"We declare that this study has not been published at all.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Previous publication"}},{"value":"We declare that we have not used AI in writing any part of this abstract.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI in scientific writing"}},{"value":"No conflict of interest.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}